Registry of Asthma Characterization and Recruitment 3 (RACR3)
Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- No age limits stated
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study builds a list of people who may join current or future studies of childhood asthma in urban areas. It does not test a treatment. Adults and children who live in a qualifying city area or its surrounding communities may join.
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- If you are 18 or older, you must be willing and able to give consent to join.
- If you are under 18, you must come with a legal guardian who is willing and able to give consent.
- Your main home must be in a Metropolitan Statistical Area, a city area and nearby communities defined by the federal government.
Who can't join
- You or your guardian do not speak English or Spanish.
- You do not have regular access to a personal or public phone for scheduling and safety checks.
- The study doctor believes a health problem or test result could make joining unsafe, make it hard to follow study rules, or affect the study's data.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Participant is either: 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA) Exclusion Criteria: 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy. Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.
Study sites (7)
CO
- Children's Hospital Colorado: Allergy Program · Aurora, CO 80045Pascuala Pinedo-Estrada · Study contact · 720-777-8077 · pascuala.pinedo-estrada@childrenscolorado.orgAndrew Liu, MD · Principal investigatorMore trials in Aurora
DC
- Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site · Washington D.C., DC 20010Alicia Mathis · Study contact · 202-476-5134 · anewcome@childrensnational.orgStephen Teach, MD · Principal investigatorMore trials in Washington D.C.
IL
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology · Chicago, IL 60611Sarah Godley · Study contact · 312-227-6451 · sgodley@luriechildrens.orgRajesh Kumar, MD · Principal investigatorMore trials in Chicago
MA
- Boston Children's Hospital: Department of Immunology · Boston, MA 02215 · Study contact · 617-919-1301Wanda Phipatanakul · Principal investigatorMore trials in Boston
NY
- Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute · New York, NY 10029Catherine Swarts · Study contact · 212-824-7982 · catherine.swarts@icahn.mssn.eduPaula Busse, MD · Principal investigatorMore trials in New York
- Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine · New York, NY 10032 · Study contact · 212-305-6270More trials in New York
OH
- Cincinnati Children's Hospital Medical Center: Asthma Center · Cincinnati, OH 45229Katy Geil · Study contact · 513-803-5178 · kathryn.geil@cchmc.orgNeeru Hershey, MD · Principal investigatorMore trials in Cincinnati